Did you know?

One person is diagnosed with a blood clot every minute. One person dies from a blood clot every six minutes.

News & Events

Patient education video now online more...

World Thrombosis Day is October 13 more...

Upcoming event: Walk to increase awareness of thrombosis in infants and children more...

Venous Thromboembolism Resource 

Deep vein thrombosis (DVT) & Pulmonary embolism (PE)

Clot Connect is an information and outreach project at the University of North Carolina at Chapel Hill Hemophilia and Thrombosis Center. Clot Connect provides patients and healthcare professionals connection to clinically relevant education resources on deep vein thrombosis, pulmonary embolism, thrombophilia and anticoagulation.   

 

Newly diagnosed with deep vein thrombosis (DVT) or pulmonary embolism (PE)?  

Start your search for information here.  

From our Patient Blog

New Oral Blood Thinner FDA Approved – Bevyxxa (Betrixaban)

Stephan Moll, MD writes… Today, June 23, 2017, the FDA approved a 5th new oral blood thinner for clinical use, Bevyxxa® (= Betrixaban), taken once daily. It is FDA approved to prevent blood clots (DVT and PE) for patients who are significantly immobile and, therefore, at increased risk for blood clots during and after hospitalization […] Read the rest of this entry »

Athletes and Blood Clots

Can Athletes With DVT or PE Return To Play? Fact-Based Rather Than Emotional Reasoning   Stephan Moll, MD1, Joshua Berkowitz, MD2, Philip Blatt, MD, FACP3   Every so often news hit the media that a prominent athlete has had a blood clot: NBA athlete Chris Bosh and NHL’s Steven Stamkos most recently, NBA’s Mirza Teletović and […] Read the rest of this entry »

From our Healthcare Professionals Blog

New Oral Anticoagulant FDA Approved – Bevyxxa (Betrixaban)

Stephan Moll, MD writes… Today, June 23, 2017, the FDA approved a 5th new oral anticoagulant for clinical use, Bevyxxa® (= Betrixaban). It is FDA approved to prevent DVT and PE in patients who are significantly immobile during and after hospitalization for an acute medical illness. Full prescribing information: here.  FDA details: here. In the APEX […] Read the rest of this entry »

Athletes and Blood Clots

Stephan Moll, MD writes: Athletes with DVT or PE and on anticoagulation face significant challenges returning to full athletic activities. A recent publication of the American College of Cardiology discusses individualized management regimens that may return athletes to return to their sport – http://www.bit.ly/2erRLc0.   Last updated: Oct 30th, 2016 Read the rest of this entry »